High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial
10th treatment shown to reduce risk in
December 2020 *, now known with p = 0.0000002 from 18 studies.
|
RCT 67 extremely late stage intubated patients in Iran, showing lower CRP with melatonin treatment, but no significant difference in outcomes.
This study is excluded in the after exclusion results of meta
analysis:
extremely late treatment, over 75% control mortality.
risk of death, 3.8% lower, RR 0.96, p = 0.73, treatment 28 of 33 (84.8%), control 30 of 34 (88.2%), NNT 30.
|
risk of no extubation, 13.6% lower, RR 0.86, p = 0.19, treatment 26 of 33 (78.8%), control 31 of 34 (91.2%), NNT 8.1.
|
ventilation time, 27.0% lower, relative time 0.73, p = 0.09, treatment 33, control 34.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Alizadeh et al., 13 May 2022, Double Blind Randomized Controlled Trial, placebo-controlled, Iran, peer-reviewed, 11 authors, study period June 2020 - September 2020.
Contact:
h-hosami@sina.tums.ac.ir.
Abstract: JTUMED916_proof ■ 13 May 2022 ■ 1/7
Journal of Taibah University Medical Sciences (xxxx) xxx(xxx), xxx
Taibah University
Journal of Taibah University Medical Sciences
www.sciencedirect.com
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
Original Article
High dose melatonin as an adjuvant therapy in intubated patients with
Q2 COVID-19: A randomized clinical trial
Nafiseh Alizadeh a, Mehrnoush Dianatkhah b, Yousef Alimohamadi c, Hazhir Moradi d,
Samaneh Akbarpour e, Majid Akrami f, Fariba Mansouri g, Neda Faraji g, Zahra Rezaie h,
i
i,
Q3 Mahboubeh Alizadeh and Hadiseh Hosamirudsari *
Q18
a
Department of Pharmaceutical Care, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran
Department of Clinical Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
c
Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Q4
d
Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
Q5
e
Occupational Sleep Research Center, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran
f
Department of Anesthesiology, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran
g
Department of Internal Medicine, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran
h
Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
i
Department of Infectious Diseases, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran
b
Received 13 February 2022; revised 11 April 2022; accepted 28 April 2022; Available online - - -
ﺍﻟﻤﻠﺨﺺ
ﺍﻟﻤﻼﻳﻴﻦ ﻣﻦ ﺍﻟﻨﺎﺱ ﻓﻲ ﺟﻤﻴﻊ ﺃﻧﺤﺎﺀ19- ﺃﺻﺎﺑﺖ ﺟﺎﺋﺤﺔ ﻛﻮﻓﻴﺪ:ﺃﻫﺪﺍﻑ ﺍﻟﺒﺤﺚ
ﻣﻦ ﺍﻟﻤﻌﺮﻭﻑ ﺃﻥ ﺟﺮﻋﺔ. ﺗﺮﺟﻊ ﺍﻟﻮﻓﻴﺎﺕ ﺃﺳﺎﺳﺎ ﻟﺤﺎﻟﺔ ﺍﻻﻟﺘﻬﺎﺏ ﻭﻣﻀﺎﻋﻔﺎﺗﻪ.ﺍﻟﻌﺎﻟﻢ
ﻗﻴﻤﺖ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ ﺟﺮﻋﺔ.ﻋﺎﻟﻴﺔ ﻣﻦ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﺗﻌﺘﺒﺮ ﻋﺎﻣﻼ ﻣﻀﺎﺩﺍ ﻟﻼﻟﺘﻬﺎﺑﺎﺕ
ﻋﺎﻟﻴﺔ ﻣﻦ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﻛﻌﻼﺝ ﻣﺴﺎﻋﺪ ﻓﻲ ﺍﻟﺤﺎﻻﺕ ﺍﻟﺤﺮﺟﺔ ﻟﻠﻤﺮﺿﻰ ﺍﻟﻤﺼﺎﺑﻴﻦ
.19-ﺑﻌﺪﻭﻯ ﻛﻮﻓﻴﺪ
ﻣﻠﻎ21 ﺃﺟﺮﻳﻨﺎ ﺗﺠﺮﺑﺔ ﺳﺮﻳﺮﻳﺔ ﻋﺸﻮﺍﺋﻴﺔ ﻣﺰﺩﻭﺟﺔ ﺍﻟﺘﻌﻤﻴﺔ ﻟﺠﺮﻋﺔ:ﻃﺮﻕ ﺍﻟﺒﺤﺚ
ﺗﻢ.19- ﻣﺮﻳﻀﺎ ﻛﻮﻓﻴﺪ67 ﻣﻦ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﻓﻲ ﺍﻟﻴﻮﻡ ﻣﻘﺎﺭﻧﺔ ﻣﻊ ﺩﻭﺍﺀ ﻭﻫﻤﻲ ﺑﻴﻦ
ﺍﻟﻤﻮﺛﻘﺔ19- ﻋﺎﻣﺎ ﻭﺍﻟﻤﺼﺎﺑﻴﻦ ﺑﻌﺪﻭﻯ ﻛﻮﻓﻴﺪ18 ﺍﻟﺘﺴﺠﻴﻞ ﻟﻠﻤﺮﺿﻰ ﺍﻷﻛﺒﺮ ﻣﻦ
ﺍﺳﺘﻤﺮ.ﻭﺍﻟﺬﻳﻦ ﺗﻢ ﺇﺩﺧﺎﻟﻬﻢ ﺇﻟﻰ ﻭﺣﺪﺓ ﺍﻟﻌﻨﺎﻳﺔ ﺍﻟﻤﺮﻛﺰﺓ ﻭﺧﻀﻌﻮﺍ ﻟﺘﻬﻮﻳﺔ ﻣﻴﻜﺎﻧﻴﻜﻴﺔ
.ﺇﻋﻄﺎﺀ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﻭﺍﻟﻌﻼﺝ ﺍﻟﻮﻫﻤﻲ ﻟﻤﺪﺓ ﺧﻤﺴﺔ ﺃﻳﺎﻡ ﻣﻦ ﺧﻼﻝ ﺃﻧﺒﻮﺏ ﺃﻧﻔﻲ ﻣﻌﺪﻱ
ﻭﺍﻟﺘﻐﻴﺮﺍﺕ ﻓﻲ، ﻭﻣﺪﺓ ﺍﻟﺘﻬﻮﻳﺔ ﺍﻟﻤﻴﻜﺎﻧﻴﻜﻴﺔ،ﻛﺎﻧﺖ ﺍﻟﻨﺘﺎﺋﺞ ﺍﻟﺮﺋﻴﺴﻴﺔ ﻣﻌﺪﻝ ﺍﻟﻮﻓﻴﺎﺕ
. ﻭﻣﺴﺘﻮﻳﺎﺕ ﺍﻟﺒﺮﻭﺗﻴﻦ ﺍﻟﻤﺘﻔﺎﻋﻞ ﺳﻲ،ﻣﺆﺷﺮﺍﺕ ﺍﻷﻭﻛﺴﺠﻴﻦ
ﻟﻢ ﻳﻜﻦ ﻫﻨﺎﻙ ﻓﺮﻕ ﺟﻮﻫﺮﻱ ﻓﻲ ﺍﻟﻮﻓﻴﺎﺕ ﻭﻣﺪﺓ ﺍﻟﺘﻬﻮﻳﺔ ﺍﻟﻤﻴﻜﺎﻧﻴﻜﻴﺔ ﺑﻴﻦ:ﺍﻟﻨﺘﺎﺋﺞ
ﺍﻟﻤﺘﻮﺳﻂ ) ﺍﻻﻧﺤﺮﺍﻑ، ﺃﻳﺎﻡ ﻣﻦ ﺍﻟﺘﺪﺧﻞ5 ﺑﻌﺪ.ﻣﺠﻤﻮﻋﺎﺕ ﺍﻟﺘﺤﻜﻢ ﻭﺍﻟﺘﺪﺧﻞ
* Corresponding address: Department of Infectious Disease,
Baharloo Hospital, Tehran University of Medical Sciences, Behdari
Q6 Street, Railway Square, Tehran, Iran.
E-mail: h-hosami@sina.tums.ac.ir (H. Hosamirudsari)
Peer review under responsibility of Taibah University.
Production and hosting by Elsevier
) 47.28 ﺍﻟﻤﻌﻴﺎﺭﻱ( ﻟـﻠﺒﺮﻭﺗﻴﻦ ﺍﻟﻤﺘﻔﺎﻋﻞ ﺳﻲ ﻭ ﻋﺪﺩ ﺍﻟﺼﻔﺎﺋﺢ ﺍﻟﺪﻣﻮﻳﺔ ﻛﺎﻥ
ﻣﻴﻜﺮﻭﻟﺘﺮ ﻓﻲ ﻣﺠﻤﻮﻋﺔ/ 1000 (87.13 ) 195.73 ﻟﺘﺮ ﻭ/ ( ﻣﻠﻐﻢ38.86
/ 1000 (68.03 ) 149.62 ﻟﺘﺮ ﻭ/ ( ﻣﻠﻐﻢ48.02 ) 75.52 ﺍﻟﺘﺪﺧﻞ ﻭ
.ﻣﻴﻜﺮﻭﻟﺘﺮ ﻓﻲ ﻣﺠﻤﻮﻋﺔ ﺍﻟﺘﺤﻜﻢ ﻋﻠﻰ ﺍﻟﺘﻮﺍﻟﻲ
19- ﺍﺭﺗﺒﻂ ﺗﻨﺎﻭﻝ ﺟﺮﻋﺎﺕ ﻋﺎﻟﻴﺔ ﻣﻦ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ ﻓﻲ ﻣﺮﺿﻰ ﻛﻮﻓﻴﺪ:ﺍﻻﺳﺘﻨﺘﺎﺟﺎﺕ
ﻓﺈﻥ ﺗﺄﺛﻴﺮﻩ ﻋﻠﻰ ﻧﺘﺎﺋﺞ، ﻭﻣﻊ ﺫﻟﻚ.ﺑﺎﻟﺘﻨﺎﻗﺺ ﻓﻰ ﻣﺴﺘﻮﻳﺎﺕ ﺍﻟﺒﺮﻭﺗﻴﻦ ﺍﻟﻤﺘﻔﺎﻋﻞ ﺳﻲ
.ﺍﻟﻤﺮﺿﻰ ﻟﻢ ﻳﻜﻦ ﻣﻠﺤﻮﻇﺎ
؛ ﺍﻟﻤﻴﻼﺗﻮﻧﻴﻦ؛ ﺗﻨﺒﻴﺐ؛ ﻣﻌﺪﻝ ﺍﻟﻮﻓﻴﺎﺕ؛ ﺍﻟﻌﻼﺝ19- ﻛﻮﻓﻴﺪ:ﺍﻟﻜﻠﻤﺎﺕ..
Late treatment
is less effective
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers.
Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit